If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 508.00
Bid: 506.00
Ask: 510.00
Change: -2.00 (-0.39%)
Spread: 4.00 (0.791%)
Open: 510.00
High: 510.00
Low: 506.00
Prev. Close: 508.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes; Update re: Returns of Capital

18 Mar 2024 07:00

RNS Number : 1415H
Marlowe PLC
18 March 2024
 

18 March 2024

 

Marlowe plc

("Marlowe" or the "Company")

 

Board Changes; Update re: Returns of Capital

 

Further to the announcement of 22 February 2024 on the sale of certain Governance, Risk & Compliance ("GRC") software and services assets (the "Divestment") for an Enterprise Value of £430m, Marlowe plc ("Marlowe" or the "Group") announces the following changes to its Board:

 

· The appointment of Lord Ashcroft KCMG PC as a Non-Executive Director.

 

· Charles Skinner is today stepping down from the Marlowe Board, having been in role since the company's formation and through to its growth into the UK leader in business-critical services and software. Charles will be replaced by a new Independent Non-Executive Director in due course.

 

 

Update re: Returns of Capital on completion of the Divestment

 

The Group also provides an update on the planned process to return capital to shareholders following completion of the Divestment.

 

Subject to completion, proposed returns of capital would be expected to commence during the first half of the Group's FY25 financial year, beginning 1 April 2024.

 

? After relevant adjustments including estimated transaction costs, settlement of certain transaction-related liabilities and earn-outs, reorganisation and separation costs, the Group expects net Divestment sale proceeds to be c.£405 million.

 

? On completion of the Divestment and the retirement in full of the Group's existing debt facilities, the Group expects its net cash position to be approximately £220 million.

 

? The Group is minded to retain a net cash balance to provide resources for working capital and selected investments and to return in excess of £150 million of remaining net cash to shareholders.

 

? The Board is assessing the optimal route through which to effect the return of capital and will confirm the return in due course.

 

Kevin Quinn, Non-Executive Chairman of Marlowe, commented:

 

"The Board wishes to wholeheartedly thank Charles for his service and commitment to Marlowe. He has served on the Board from the earliest days of Marlowe and has made an outstanding contribution throughout his tenure. He goes with our best wishes for the future.

 

We welcome Lord Ashcroft to the Board of Marlowe."

 

The directorships and partnerships currently held by Michael Anthony Ashcroft, aged 78, and over the five years preceding the date of his appointment, are as follows:

 

Current directorships / partnerships

Previous directorships / partnerships

Impellam Group plc

Imperial War Museum

Merit Group plc

Imperial War Museum Foundation

Waterloo Investment Holdings Limited

Rendeavour Holdings Limited

Heather Global plc

Crimestoppers Trust

Prospect Education (Technology) Trust Limited

 

Lord Ashcroft currently holds 11,877,361 Ordinary Shares in Marlowe, representing 12.3% of the Company's issued share capital.

 

For further information:

 

Marlowe plc

Alex Dacre, Chief Executive

www.marloweplc.com

Adam Councell, Chief Financial Officer

Tel: +44 (0) 203 813 8498

Benjamin Tucker, Head of Investor Relations

Cavendish Capital Markets (Nominated Adviser and Joint Broker)

Ben Jeynes

Tel: +44 (0)20 7220 0500

George Lawson

Berenberg (Joint Broker)

Dan Gee-Summons

Tel: +44 (0)20 3207 7800

Mark Whitmore

Stifel (Joint Broker)

Matthew Blawat

Tel: +44 (0)20 7710 7688

Francis North

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

 

About Marlowe plc

 

Marlowe is a UK leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQDLFFZXLLBBD
Date   Source Headline
22nd Feb 20215:20 pmRNSDirector/PDMR Shareholding
17th Feb 20213:30 pmRNSCapital Markets Day Replay
17th Feb 20217:00 amRNSCapital Markets Day and Trading Update
10th Feb 20217:00 amRNSNotice of Capital Markets Day
5th Feb 20217:00 amRNSIssue of Equity and Director/PDMR Shareholding
4th Feb 20217:00 amRNSAcquisition Hadrian Technology Limited
28th Jan 20212:45 pmRNSHolding(s) in Company
7th Jan 20217:00 amRNSAcquisition of WPL Limited
29th Dec 20204:40 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSAcquisition of DeltaNet International Limited
11th Dec 20206:07 pmRNSHolding(s) in Company
11th Dec 202011:25 amRNSResult of General Meeting
7th Dec 20207:00 amRNSAcquisition of Network of Staff Supporters Limited
3rd Dec 20207:00 amRNSHalf Year Results
1st Dec 20204:10 pmRNSCompletion of Acquisition
30th Nov 20207:00 amRNSAcquisition of Wrightway Health Limited
26th Nov 20203:30 pmRNSNotice of General Meeting
20th Nov 20207:00 amRNSCompletion of Refinancing
17th Nov 202011:59 amRNSHolding(s) in Company
3rd Nov 202010:58 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSAcquisition of Black & Banton
30th Oct 202011:55 amRNSHolding(s) in Company
29th Oct 20206:08 pmRNSHolding(s) in Company
29th Oct 20207:00 amRNSResults of the Placing
28th Oct 20205:08 pmRNSAcquisition of Ellis Whittam and Proposed Placing
30th Sep 202012:06 pmRNSResult of AGM
25th Sep 20207:00 amRNSAcquisition of Morgan Fire Protection Limited
9th Sep 20207:00 amRNSFurther re Acquisition of William Martin
2nd Sep 20207:00 amRNS2020 SAYE Scheme & Director/PDMR Shareholdings
31st Jul 20202:46 pmRNSIssue of Equity and Director/PDMR Shareholding
31st Jul 20207:00 amRNSAcquisitions
17th Jul 202012:20 pmRNSHolding(s) in Company
15th Jul 202011:20 amRNSResult of General Meeting
8th Jul 20204:03 pmRNSGrant of Share Options
8th Jul 20207:00 amRNSFinal Results
30th Jun 202011:57 amRNSHolding(s) in Company
26th Jun 20202:39 pmRNSResults of the Placing
26th Jun 20207:00 amRNSAcquisition of Elogbooks and Proposed Placing
29th May 20207:00 amRNSAcquisition of Deminos Consulting Limited
12th May 20207:00 amRNSYear End Trading Statement and COVID-19 Update
7th Apr 202012:40 pmRNSIssue of Equity
7th Apr 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDisposal of non-core activities
31st Mar 20207:00 amRNSUpdate on COVID-19
24th Mar 202011:31 amRNSIssue of Equity
11th Mar 202011:24 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNSAcquisition of Solve HR Limited
9th Mar 20207:00 amRNSAcquisition of Managed Occupational Health Limited
3rd Feb 20207:00 amRNSAcquisition of Eurosafe UK Group Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.